Copper

2

Review clinical trials related to Copper. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Correlation and Predictive Research of Metal Elements in Radiation-Induced Oral Mucositis

Radiotherapy is the main treatment method for head and neck tumors. However, almost all patients with head and neck tumors will develop acute inflammatory reactions such as Radiotherapy-Induced Oral Mucositis (RIOM) after receiving Radiotherapy, resulting in a decline in the quality of life of patients, hindering the smooth implementation of the treatment plan, reducing the therapeutic effect, and increasing the economic burden of patients. However, the current treatment strategies for RIOM focus on symptomatic treatment and have little impact on the course, severity and related complications of mucositis. Therefore, exploring effective strategies, predicting the incidence and severity of RIOM in patients, and providing prevention and treatment are the clinical bottlenecks and cutting-edge issues that urgently need to be solved in the current clinical practice of radiotherapy for head and neck tumors. Previous studies have shown that the steady-state of metallic elements may be closely related to the occurrence and development of RIOM. Therefore, we plan to conduct a prospective, single-center, observational study to further explore the correlation between metal elements and severe RIOM, analyze its predictive efficacy, and observe the dynamic changes of metal elements in radiotherapy.

Participants needed: 383
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Nanfang Hospital, Southern Medical UniversityUpdated: May 13, 2025Locations: 1
Eligibility criteria

There are contraindications for radiotherapy; [+4]

Status: Recruiting

The Correlation Between Ovarian Function and Serum Biomarkers

The goal of this observational study is to find differences in serum biomarkers between ovarian function and normal individuals.

Participants needed: 35
Trial details
Age: 18-45Biological sex: FemaleType: ObservationalSponsor: Shi YunUpdated: Dec 9, 2024Locations: 1
Eligibility criteria

The selection criteria for healthy individuals are follows. [+12]

Patients with congenital gonadal developmental abnormalities or a family history... [+5]